Tetragon Financial Management LP → Silence Therapeutics plc SLNCF

Stake: — Shares: — Class: Ordinary Shares, nominal value 0.05 GBP per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 130.56

2,350 shares short · 0.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $694K

Point72 Asset Mgmt

Other 13D/G Filings on Silence Therapeutics plc

Filed	Form	Filer	Stake	Shares
2026-08-13	SCHEDULE 13D/A	Griffiths Richard Ian	—	14,391,498	view →
2026-07-08	SCHEDULE 13D/A	Griffiths Richard Ian	21.70%	30,844,458	view →
2023-08-14	SC	Griffiths Richard Ian	—	—	view →
2022-07-20	SC	Griffiths Richard Ian	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →